Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 11Carcinoma, Non-Small-Cell Lung 9Recurrence 7Colorectal Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Lymphoma, T-Cell, Peripheral 4Colonic Neoplasms 4Rectal Neoplasms 3Lymphoma, T-Cell 3Lung Neoplasms 3Sezary Syndrome 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Infertility 2Hyperandrogenism 2Head and Neck Neoplasms 2Breast Neoplasms 2Atypical Squamous Cells of the Cervix 2Anovulation 2Adenoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Thrombocytopenia 1

Interventions

epigallocatechin gallate 1Vitamin B 12 1Sugars 1Maltose 1Interferon-alpha 1Hyaluronic Acid 1Folic Acid 1Cidofovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Papilloma × Folic Acid × Clear all
NCT05625308 2022-12-22

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Lo.Li.Pharma s.r.l

Phase NA Completed
40 enrolled

Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡